AMARIN CORP PLC\UK Capital Leases, Future Minimum Payments Due in Three Years
AMARIN CORP PLC\UK (AMRN) had Capital Leases, Future Minimum Payments Due in Three Years of $3.00 thousand as of 2012-12-31, per its 10-K filed 2013-02-28.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2013-02-28
- 2012-12-31: Capital Leases, Future Minimum Payments Due in Three Years $3.00K.
- 2011-12-31: Capital Leases, Future Minimum Payments Due in Three Years $7.00K.
| Period end | Capital Leases, Future Minimum Payments Due in Three Years |
|---|---|
| 2012-12-31 | $3.00K 10-K · filed 2013-02-28 |
| 2011-12-31 | $7.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |